NCT05864534 Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma Status RECRUITING Phase PHASE2
NCT05843253 Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant Status RECRUITING Phase PHASE2
NCT05769660 A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM) Status RECRUITING Phase PHASE1
NCT05756985 Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue Status RECRUITING Phase N/A
NCT05708352 A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment Status RECRUITING Phase PHASE2
NCT05686798 Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. Status RECRUITING Phase PHASE1
NCT05624736 Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning Status UNKNOWN Phase N/A
NCT05608395 11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET) Status COMPLETED Phase PHASE2
NCT05589961 Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme Status UNKNOWN Phase EARLY_PHASE1
NCT05565326 Response Assessment During MR-guided Radiation Therapy for Glioblastoma Status RECRUITING Phase N/A
NCT05563272 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors Status TERMINATED Phase PHASE2
NCT05561374 Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05551013 Treatment of Recurrent GBM With APG-157 Via Expanded Access Status NO_LONGER_AVAILABLE Phase N/A
NCT05500612 MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy Status RECRUITING Phase N/A
NCT05495295 First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours Status RECRUITING Phase PHASE1
NCT05450744 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) Status RECRUITING Phase PHASE1
NCT05432375 Study of Tinostamustine for Adjuvant Treatment of Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT05423210 Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme Status RECRUITING Phase EARLY_PHASE1
NCT05402241 IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study Status COMPLETED Phase N/A